Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
Journal of Neuro-Oncology
|
June 20, 2003
Psychometric- and quality-of-life assessment in long-term glioblastoma survivors
Manuela Schmidinger, Leo Linzmayer, Alexander Becherer, et al.
Nature Reviews. Disease Primers
|
March 10, 2017
Renal cell carcinoma
James J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 5, 2002
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy
Catharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
June 8, 2001
Sequential Administration of Interferon-gamma, GM-CSF, and Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma: Results of a Phase II Trial
Manuela Schmidinger, Guenther Steger, Catharina Wenzel, et al.
Anticancer Research
|
November 14, 2013
A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer
Chiara Paglino, Giuseppe Procopio, Roberto Sabbatini, et al.
Wiener Medizinische Wochenschrift (1946)
|
July 3, 2003
[Aerobic endurance training for cancer patients]
Richard Crevenna, Christoph Zielinski, Mohammad Yahya Keilani, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2020
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis
Keiichiro Mori, Hadi Mostafaei, Noriyoshi Miura, et al.
Clinical Genitourinary Cancer
|
November 1, 2019
Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis
Melanie R Hassler, Mohammad Abufaraj, Shoji Kimura, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2015
Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: results of a pooled analysis of non-interventional studies
Laurence Albiges, Ulrich Kube, Jean-Christophe Eymard, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2022
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
Stefano Fogli, Fabrizio Tabbò, Annalisa Capuano, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
Journal of Neuro-Oncology
|
June 20, 2003
Psychometric- and quality-of-life assessment in long-term glioblastoma survivors
Manuela Schmidinger, Leo Linzmayer, Alexander Becherer, et al.
Nature Reviews. Disease Primers
|
March 10, 2017
Renal cell carcinoma
James J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 5, 2002
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy
Catharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
June 8, 2001
Sequential Administration of Interferon-gamma, GM-CSF, and Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma: Results of a Phase II Trial
Manuela Schmidinger, Guenther Steger, Catharina Wenzel, et al.
Anticancer Research
|
November 14, 2013
A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer
Chiara Paglino, Giuseppe Procopio, Roberto Sabbatini, et al.
Wiener Medizinische Wochenschrift (1946)
|
July 3, 2003
[Aerobic endurance training for cancer patients]
Richard Crevenna, Christoph Zielinski, Mohammad Yahya Keilani, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2020
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis
Keiichiro Mori, Hadi Mostafaei, Noriyoshi Miura, et al.
Clinical Genitourinary Cancer
|
November 1, 2019
Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis
Melanie R Hassler, Mohammad Abufaraj, Shoji Kimura, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2015
Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: results of a pooled analysis of non-interventional studies
Laurence Albiges, Ulrich Kube, Jean-Christophe Eymard, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2022
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
Stefano Fogli, Fabrizio Tabbò, Annalisa Capuano, et al.
Page
of 12